Home > Academics > Academic Units > Faculty of Interdisciplinary Sciences & Engineering > Nano Science and Technology > Shivendu Ranjan
Nano-Bio Interface LaboratorY (nano-BILY)
We, the nano-BILYans, are an interdisciplinary research group, working in translating nanotechnology for biomedical applications. nano-BILY is developing group of members coming from a variety of backgrounds, including biotechnology, polymer technology, materials science, chemistry, physiology, and pharmacy. nano-BILY also include collaborative team of academicians, scientists, clinicians, and industry personnel. The following themes is the current focus of nano-BILY:
Nanomedicine and Drug / Gene Delivery
nano-BILY will be focussing on taking up the existing challenges in biomedical sector to develop prototypes / products / processes for nano-formulations for different drug / gene delivery. We are aiming on safely and efficiently translating new therapeutic agents from bench to bedside with the goal of improving human health.
Biomaterials and Regenerative Medicine
At the current stage, nano-BILY is working on engineering nanomaterials for their possible applications in bone, wound, and inflammatory diseases. The interdisciplinary team of academicians, clinicians, industry personnel, and scientists are focussing to solve the challenge in collaboration.
Nanomaterials – Biomolecule Interaction
The nano–bio interactions will not only influence the function and fate of nano-formulations, but also affect the therapeutic behaviour of the formulation. Understanding the behaviour of nano-formulations in biological environment is also a focus of nano-BILY. Nano-BILY is focussing to evaluate the basic mechanisms of the reactions at nanomaterial–biology (nano–bio) interfaces and find strategies to manipulate the nano–bio reactions for its biomedical applications.
The additional approach of nano-BILY will be to engineer the nano-formulations for the efficient nutraceuticals with a focus to solve the nutritional deficiency in human health. Safe production and use of nanomaterials require effective risk management. For this purpose, we combine nano-related exposure and toxicity knowledge to develop processes and procedures for risk assessment and management of nanomaterials.
Area of Research: Nanomaterials application in Biotechnology